Literature DB >> 4066523

An energy-dependent step in aminoglycoside ototoxicity: prevention of gentamicin ototoxicity during reduced endolymphatic potential.

A Takada, S Bledsoe, J Schacht.   

Abstract

Guinea pigs received a bolus of gentamicin (10 mM for 5 min) by perilymphatic perfusion which normally led to an irreversible loss of the cochlear microphonic potential (CM). Various experimental conditions that reduced the endolymphatic potential (EP) were then superimposed on the gentamicin application. Reversible reductions in EP (and, concomitantly, in CM) were induced by asphyxia (3 min), intravenous furosemide (50 mg/kg), and perilymphatic perfusion of aminooxyacetic acid (10 mM). When the administration of gentamicin was initiated at the time of maximal EP reduction the usual irreversible gentamicin-induced decline of CM was prevented. The results indicate that a metabolic process is essential in the expression of gentamicin toxicity. The data are consistent with the inhibition of an energy-dependent transport of the aminoglycoside. Alternatively, the data are also compatible with the hypothesis that entry of gentamicin into hair cells is prevented by a reduction in their transmembrane electrical potential.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4066523     DOI: 10.1016/0378-5955(85)90144-3

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  7 in total

Review 1.  Drug-induced tinnitus and other hearing disorders.

Authors:  H Seligmann; L Podoshin; J Ben-David; M Fradis; M Goldsher
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

2.  Distribution of gentamicin in the guinea pig inner ear after local or systemic application.

Authors:  Shun-Ichi Imamura; Joe C Adams
Journal:  J Assoc Res Otolaryngol       Date:  2003-06

3.  Competitive antagonism of fluorescent gentamicin uptake in the cochlea.

Authors:  Qi Wang; Allan Kachelmeier; P S Steyger
Journal:  Hear Res       Date:  2010-06-16       Impact factor: 3.208

4.  Antioxidant treatment with coenzyme Q-ter in prevention of gentamycin ototoxicity in an animal model.

Authors:  A R Fetoni; S L M Eramo; R Rolesi; D Troiani; G Paludetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2012-04       Impact factor: 2.124

Review 5.  Drug-induced ototoxicity. Pathogenesis and prevention.

Authors:  M Y Huang; J Schacht
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

6.  Trafficking of systemic fluorescent gentamicin into the cochlea and hair cells.

Authors:  Qi Wang; Peter S Steyger
Journal:  J Assoc Res Otolaryngol       Date:  2009-03-03

7.  Development of an ototoxicity model in the adult CBA/CaJ mouse and determination of a golden window of corticosteroid intervention for otoprotection.

Authors:  Vinay T Fernandes; Vincent Y W Lin
Journal:  J Otolaryngol Head Neck Surg       Date:  2014-04-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.